Free Trial

Oracle (ORCL) Stock Forecast & Price Target

Oracle logo
$154.98 +2.75 (+1.80%)
Closing price 03/24/2025 03:59 PM Eastern
Extended Trading
$154.74 -0.24 (-0.15%)
As of 03/24/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
12
Buy
16

Based on 28 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 12 have given a hold rating, 15 have given a buy rating, and 1 has given a strong buy rating for ORCL.

Consensus Price Target

$179.20
15.63% Upside
According to the 28 analysts' twelve-month price targets for Oracle, the average price target is $179.20. The highest price target for ORCL is $220.00, while the lowest price target for ORCL is $130.00. The average price target represents a forecasted upside of 15.63% from the current price of $154.98.
Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

Sign Up

ORCL Analyst Ratings Over Time

TypeCurrent Forecast
3/25/24 to 3/25/25
1 Month Ago
2/24/24 to 2/23/25
3 Months Ago
12/26/23 to 12/25/24
1 Year Ago
3/26/23 to 3/25/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
18 Buy rating(s)
17 Buy rating(s)
14 Buy rating(s)
Hold
12 Hold rating(s)
10 Hold rating(s)
10 Hold rating(s)
9 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$179.20$182.73$181.48$130.76
Forecasted Upside15.63% Upside8.82% Upside5.87% Upside3.72% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oracle Stock vs. The Competition

TypeOracleComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.61
2.69
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside15.63% Upside629.15% Upside16.93% Upside
News Sentiment Rating
Positive News

See Recent ORCL News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/19/2025Stephens
4 of 5 stars
Brett Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$167.00+11.72%
3/12/2025Citigroup
3 of 5 stars
Tyler Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$194.00 ➝ $160.00+5.27%
3/11/2025UBS Group
4 of 5 stars
 Reiterated RatingMarket Perform ➝ Market Perform
3/11/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetSector Perform ➝ Sector Perform$145.00-0.77%
3/11/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gil Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$150.00 ➝ $150.00+5.18%
3/11/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Murphy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$140.00 ➝ $135.00-4.12%
3/11/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jackson Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00+41.95%
3/11/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Blakey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$214.00 ➝ $175.00+25.43%
3/11/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Bachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetMarket Perform ➝ Market Perform$205.00 ➝ $175.00+17.55%
3/11/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raimo Lenschow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$212.00 ➝ $202.00+35.69%
3/11/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$210.00 ➝ $190.00+27.63%
3/11/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$195.00 ➝ $175.00+17.55%
3/11/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kirk Materne
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$200.00 ➝ $185.00+24.27%
3/11/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$175.00 ➝ $170.00+14.19%
3/11/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Reback
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$175.00 ➝ $150.00+0.76%
3/5/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$220.00 ➝ $220.00+38.91%
3/3/2025Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
1/22/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$205.00 ➝ $205.00+11.77%
12/10/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
12/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$185.00 ➝ $210.00+10.21%
12/5/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$190.00 ➝ $220.00+16.90%
9/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$201.00 ➝ $202.00+19.71%
9/16/2024Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/10/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
9/10/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$165.00 ➝ $180.00+28.65%
6/18/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$145.00 ➝ $159.00+11.83%
6/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$150.00 ➝ $165.00+18.39%
3/13/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$144.00 ➝ $155.00+21.42%
3/13/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$115.00 ➝ $130.00+1.83%
3/12/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Naji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
12/22/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
12/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$140.00 ➝ $130.00+12.96%
11/13/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/21/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$82.50 ➝ $110.00-2.54%
9/14/2023DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$125.00+11.77%
6/13/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:14 AM ET.


Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, March 22, 2025. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Oracle:

  • Oracle's stock is currently trading at $152.83, reflecting a stable market position and potential for growth.
  • The company has a strong market capitalization of $427.45 billion, indicating robust financial health and investor confidence.
  • Recent insider trading shows CEO Safra Catz sold a significant number of shares, which could indicate a strategic repositioning or confidence in the company's future performance.
  • Oracle has seen increased institutional investment, with 42.44% of its stock owned by institutional investors, suggesting strong backing from financial institutions.
  • The company has a solid price-to-earnings (P/E) ratio of 37.37, which, while high, can indicate growth potential in a tech-driven market.

Oracle
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Oracle for these reasons:

  • Oracle's high debt-to-equity ratio of 5.65 raises concerns about financial leverage and the company's ability to manage its debt effectively.
  • The stock has experienced volatility, with a 12-month high of $198.31 and a low of $112.78, indicating potential risks for investors.
  • Recent insider selling by the CEO, while potentially strategic, could also signal a lack of confidence in the stock's short-term performance.
  • The company's quick ratio of 0.81 suggests that it may struggle to meet short-term liabilities, which could be a red flag for investors.
  • Despite recent growth, the P/E ratio of 37.37 may indicate that the stock is overvalued compared to its earnings, which could deter value-focused investors.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $179.20, with a high forecast of $220.00 and a low forecast of $130.00.

28 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There are currently 12 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 15.63% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 3 upgrades and 1 downgrade by analysts.

Analysts like Oracle less than other "computer and technology" companies. The consensus rating score for Oracle is 2.61 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how ORCL compares to other companies.


This page (NYSE:ORCL) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners